Brasada Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
O
CCA
Brasada Capital Management's RGEN Position: Q3 2018 in Review
Brasada Capital Management sold out of Repligen (RGEN) in Q3 2018, closing a stake of 50 shares — an estimated $2K sold.
Brasada Capital Management first reported a position in RGEN in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q2 2018. 201 funds tracked by Wall St. Rank hold RGEN as of Q3 2018.
- Brasada Capital Management reported no remaining Repligen position as of Q3 2018 after selling out during the quarter.
- Brasada Capital Management sold 50 Repligen shares in Q3 2018, an estimated $2K.
- Brasada Capital Management first reported a position in Repligen in Q4 2017 and held it in 3 quarters.
- Brasada Capital Management's Repligen position peaked at $2K in Q2 2018.
- 201 funds tracked by Wall St. Rank held Repligen as of Q3 2018.
Based on Brasada Capital Management's 13F filing for Q3 2018, filed 7 Nov 2018.